CN104288597A - 一种治疗带状疱疹的中药组合物 - Google Patents
一种治疗带状疱疹的中药组合物 Download PDFInfo
- Publication number
- CN104288597A CN104288597A CN201410480369.7A CN201410480369A CN104288597A CN 104288597 A CN104288597 A CN 104288597A CN 201410480369 A CN201410480369 A CN 201410480369A CN 104288597 A CN104288597 A CN 104288597A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- herpes zoster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 21
- 241000628997 Flos Species 0.000 claims abstract description 38
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 235000005739 manihot Nutrition 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 13
- 239000010231 banlangen Substances 0.000 claims description 9
- 241000252335 Acipenser Species 0.000 claims description 8
- 210000004712 air sac Anatomy 0.000 claims description 8
- 241000221022 Manihot Species 0.000 claims 2
- 208000002193 Pain Diseases 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 240000004507 Abelmoschus esculentus Species 0.000 abstract description 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 241000219925 Oenothera Species 0.000 abstract 1
- 235000004496 Oenothera biennis Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000000994 depressogenic effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 240000003183 Manihot esculenta Species 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000003934 Abelmoschus esculentus Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003461 brachial plexus Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000001937 intercostal nerve Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗带状疱疹的中药组合物,其特征是包括以下重量份的原料药:当归12-20份、绿萼梅8-12份、玄参8-12份、连翘12-18份、秋葵全株25-40份、月见草3-8份、薏米5-15份、鱼腥草10-20份、瓜蒌40-50份、黄芪15-25份、甘草3-10份。本发明药物组合物根据带状疱疹的致病机理研发而得,配方中各原料药协同起效,疗效显著,具有活血化瘀、疏肝散结、清热除湿、补脾益气、消肿止痛功效,能从根本上解除病因,对带状疱疹以及带状疱疹后遗神经痛有很好的治疗作用。
Description
技术领域
本发明涉及一种中药组合物,具体涉及一种能够治疗带状疱疹的中药组合物,属于中药技术领域。
背景技术
带状疱疹是由水痘-带状疱疹病毒HSV引起的急性感染性皮肤病,病毒经呼吸道黏膜进入血液形成病毒血症,发生水痘或呈隐性感染,以后病毒可长期潜伏在脊髓后根神经节或者颅神经感觉神经节内,当机体受到某种刺激(如创伤、疲劳、恶性肿瘤或病后虚弱等)导致机体抵抗力下降时,潜伏病毒被激活,沿感觉神经轴索下行到达该神经所支配区域的皮肤内复制产生水疱,同时受累神经发生炎症、坏死,产生神经痛。这种病毒侵犯后遗留炎症或神经受损所导致的神经痛统称为带状疱疹后遗神经痛,这种神经痛的自我恢复常常需要半年以上时间,因此不加干预的话这种后遗疼痛是比较顽固的,且有一些病人因长期疼痛而出现精神紧张、情绪激动、失眠等现象,进一步加剧了内分泌和神经系统的功能紊乱,导致神经恢复减慢甚至抵抗力下降,疱疹复发,疼痛经久不愈。
西医治疗通常用抗病毒药物和抗神经痛药物,一般治疗时间长,疗效不是很理想。中医认为本病多由情志内伤,肝气郁结化火,火毒外泛肌肤,或脾失健运,蕴湿化热,湿热蕴结皮肤所致;老年人血虚肝旺,湿热毒盛,气滞血瘀,肌肤失养,也可导致本病。因此,对患者施加活血化瘀、疏肝散结、清热除湿、补脾益气、消肿止痛的药物配伍将从根本上治疗本病症,且快速起效。
发明内容
本发明的目的是提供一种治疗带状疱疹的中药组合物,该中药组合物能够对带状疱疹及其后遗神经痛起到很好的治疗作用,疗效显著。
本发明具体技术方案如下:
一种治疗带状疱疹的中药组合物,其特征是包括以下重量份的原料药:当归12-20份、绿萼梅8-12份、玄参8-12份、连翘12-18份、秋葵全株25-40份、月见草3-8份、薏米5-15份、鱼腥草10-20份、瓜蒌40-50份、黄芪15-25份、甘草3-10份。
上述中药组合物中,优选包括以下重量份的原料药:当归15份、绿萼梅10份、玄参10份、连翘15份、秋葵全株30份、月见草5份、薏米10份、鱼腥草15份、瓜蒌45份、黄芪20份、甘草5份。
发明人经过多年临床研究,几经修改,得到了本发明配方,通过配方中各原料的协同配合,起到了活血化瘀、疏肝散结、清热除湿、补脾益气、消肿止痛的功效,经反复验证,对带状疱疹以及其后遗神经痛作用迅速,疗效显著。各原料药功效如下:
当归,具有补血、活血、调经止痛的功效,能够护肤美容,抗炎镇痛,保肝利胆。
绿萼梅,疏肝,和胃,化痰。治梅核气,肝胃气痛,食欲不振,头晕,瘰疬。
玄参,具有清热凉血、滋阴降火、解毒散结的功效。
连翘,具有清热解毒,消肿散结,疏散风热。主治痈肿疮毒,痰核瘰疬,外感风热,温病初起,热淋涩痛等。
秋葵,又名羊角豆、咖啡黄葵、毛茄,其全株包括秋葵的根、叶和果荚,秋葵富含丰富的维生素,具有清热利湿、保护肝脏、营养皮肤的作用。
月见草,具有活血通络、息风平肝、消肿敛疮的作用。
薏苡仁,具有健脾止泻、除痹止痛、清热排脓、清热利湿的作用。
鱼腥草,具有清热解毒,利尿消肿的作用。
瓜蒌,又名栝楼,清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满;乳痈,肺痈,肠痈肿痛,大便秘结。
黄芪,具有补气固表、利尿托毒、排脓、敛疮生肌的功效。
甘草,具有益气补中、缓急止痛、润肺止咳、泻火解毒、调和诸药的作用。
进一步的,在此基础上加入干月季花、鱼鳔、板蓝根。月季花祛瘀行气、活血止痛、消肿解毒;鱼鳔补肾益精、滋养筋脉、散瘀消肿、止血、美肤;板蓝根清热解毒。加入这三种原料药,可以提高疗效,形成的配方如下(重量份):当归12-20份、绿萼梅8-12份、玄参8-12份、连翘12-18份、秋葵全株25-40份、月见草3-8份、薏米5-15份、鱼腥草10-20份、瓜蒌40-50份、黄芪15-25份、甘草3-10份、干月季花10-18份、鱼鳔22-30份、板蓝根3-8份。优选:当归15份、绿萼梅10份、玄参10份、连翘15份、秋葵全株30份、月见草5份、薏米10份、鱼腥草15份、瓜蒌45份、黄芪20份、甘草5份、干月季花15份、鱼鳔25份、板蓝根5份。
本发明中药组合物制备方法简单,可以将各原料药直接用水煎成汤剂服用,也可以将煎成的汤剂浓缩除水,按照现有方法制成丸剂、颗粒剂、片剂等剂型。
本发明药物组合物根据带状疱疹的致病机理研发而得,配方中各原料药协同起效,疗效显著,具有活血化瘀、疏肝散结、清热除湿、补脾益气、消肿止痛的功效,能从根本上解除病因,对带状疱疹以及带状疱疹后遗神经痛有很好的治疗作用。
具体实施方式
下面,通过具体实施例对本发明进行进一步的说明,应该明白的是,下述说明仅是为了解释本发明,并不对其内容进行限定。
实施例1
本发明组合物原料药配方为:当归15g、绿萼梅10g、玄参10g、连翘15g、秋葵全株30g、月见草5g、薏米10g、鱼腥草15g、瓜蒌45g、黄芪20g、甘草5g。
制备方法为:取上述各原料药,加水没过原料药,浸泡30min后大火煎煮,水开后转中火再煮30min;按此方法水煎两次,将所得汤剂合并混匀,每天早晚各服用一半。
实施例2
本发明组合物原料药配方为:当归12g、绿萼梅8 g、玄参12g、连翘12g、秋葵全株40g、月见草3g、薏米15g、鱼腥草10g、瓜蒌50g、黄芪15g、甘草10g。
按照实施例1的方法将各原料药煎成汤剂,早晚服用。
实施例3
本发明组合物原料药配方为:当归20g、绿萼梅12 g、玄参8g、连翘18g、秋葵全株25g、月见草8g、薏米5g、鱼腥草20g、瓜蒌40g、黄芪25g、甘草3g。
按照实施例1的方法将各原料药煎成汤剂,早晚服用。
实施例4
本发明组合物原料药配方为:当归15g、绿萼梅10 g、玄参10g、连翘15g、秋葵全株30g、月见草5g、薏米10g、鱼腥草15g、瓜蒌45g、黄芪20g、甘草5g、干月季花15g、鱼鳔25g、板蓝根5g。
按照实施例1的方法将各原料药煎成汤剂,早晚服用。
实施例5
本发明组合物原料药配方为:当归12g、绿萼梅8 g、玄参12g、连翘12g、秋葵全株40g、月见草3g、薏米15g、鱼腥草10g、瓜蒌50g、黄芪15g、甘草10g、干月季花10g、鱼鳔30g、板蓝根3g。
按照实施例1的方法将各原料药煎成汤剂,早晚服用。
实施例6
本发明组合物原料药配方为:当归20g、绿萼梅12 g、玄参8g、连翘18g、秋葵全株25g、月见草8g、薏米5g、鱼腥草20g、瓜蒌40g、黄芪25g、甘草3g、干月季花18g、鱼鳔22g、板蓝根8g。
按照实施例1的方法将各原料药煎成汤剂,早晚服用。
本发明中药组合物针对带状疱疹研发,通过全面调整各脏器功能,能够从根本上除去病因。经过临床验证,本发明组合物起效迅速,疗效显著。
临床实验
一、治疗带状疱疹临床实验
1、病例来源
从本市某医院选取228名带状疱疹患者进行实验,其中男性134名,女性94名,年龄18-65岁,平均年龄42.3岁。所有患者均确诊为带状疱疹,病程在10天以内。 根据疱疹侵犯神经部分分:三叉神经区域 58人,肋间神经区域 74人,臂丛神经区域42人, 坐骨神经区域54人。
2、治疗方法
将上述患者平均分为4组,各组患者之间年龄、性别、疱疹区域大小、神经痛疼状况无显著性差异。
将各组患者分别使用实施例1、2、4、5的药物进行治疗,药物煎成汤剂服用,连煎两次,药液混合均匀分早晚两次服用。
3、疗效评定
治愈:疱疹结痂脱落,痛疼完全缓解;
显效:疱疹干瘪结痂30%以上,疼痛明显减轻;
无效:疱疹干瘪结痂30%以下,疼痛未能明显缓解。
4、实验结果
连续治疗7天后,各组患者病情变化如下表1所示:
二、治疗带状疱疹后遗神经痛临床实验
1、从本市某医院选取有带状疱疹病史,皮损消失4周后仍遗留原皮疹分布区域的针刺、灼烧疼痛等后移神经痛的患者。患者共124名,其中男性60例,女性64例,患者年龄18-60岁,平均40.1岁。患者后遗神经痛病程3个月~10个月,平均5.8个月。
2、治疗方法
将上述患者平均分为4组,各组患者之间无统计学差异。
将各组患者分别使用实施例1、2、4、5的药物进行治疗,药物煎成汤剂服用,连煎两次,药液混合均匀分早晚两次服用。
3、疗效评定
治愈:临床体征消失,无痛疼后遗症;
显效:疼痛明显减轻;
无效:疼痛无缓解。
4、实验结果
连续治疗10天后,各组患者病情变化如下表3所示:
从上述实验数据可以看出,本发明各实施例对带状疱疹及其引起的后遗神经痛有很好的治疗作用,作用迅速,见效快,疗效显著,其中实施例4的药物效果最佳。
Claims (4)
1.一种治疗带状疱疹的中药组合物,其特征是包括以下重量份的原料药:当归12-20份、绿萼梅8-12份、玄参8-12份、连翘12-18份、秋葵全株25-40份、月见草3-8份、薏米5-15份、鱼腥草10-20份、瓜蒌40-50份、黄芪15-25份、甘草3-10份。
2.根据权利要求1所述的中药组合物,其特征是包括以下重量份的原料药:当归15份、绿萼梅10份、玄参10份、连翘15份、秋葵全株30份、月见草5份、薏米10份、鱼腥草15份、瓜蒌45份、黄芪20份、甘草5份。
3.根据权利要求1或2所述的中药组合物,其特征是还包括以下重量份的原料药:干月季花10-18份、鱼鳔22-30份、板蓝根3-8份。
4.根据权利要求3所述的中药组合物,其特征是还包括以下重量份的原料药:干月季花15份、鱼鳔25份、板蓝根5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410480369.7A CN104288597B (zh) | 2014-09-19 | 2014-09-19 | 一种治疗带状疱疹的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410480369.7A CN104288597B (zh) | 2014-09-19 | 2014-09-19 | 一种治疗带状疱疹的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104288597A true CN104288597A (zh) | 2015-01-21 |
CN104288597B CN104288597B (zh) | 2017-08-25 |
Family
ID=52308708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410480369.7A Expired - Fee Related CN104288597B (zh) | 2014-09-19 | 2014-09-19 | 一种治疗带状疱疹的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104288597B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535311A (zh) * | 2016-01-13 | 2016-05-04 | 刘志杰 | 一种治疗神经痛的中药 |
CN110179853A (zh) * | 2019-07-04 | 2019-08-30 | 鲁维德 | 一种治疗带状疱疹的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0892113A (ja) * | 1994-09-26 | 1996-04-09 | Soken Kk | 米からの抗炎症剤 |
CN102430071A (zh) * | 2011-12-07 | 2012-05-02 | 黄炳炎 | 一种治疗带状疱疹的药剂 |
-
2014
- 2014-09-19 CN CN201410480369.7A patent/CN104288597B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0892113A (ja) * | 1994-09-26 | 1996-04-09 | Soken Kk | 米からの抗炎症剤 |
CN102430071A (zh) * | 2011-12-07 | 2012-05-02 | 黄炳炎 | 一种治疗带状疱疹的药剂 |
Non-Patent Citations (4)
Title |
---|
李家庚等: "《皮肤及性病证治精要》", 31 January 2002 * |
杨山等: ""中西医结合治疗眼部带状疱疹28例"", 《中国中西医结合杂志》 * |
王瑛: ""48例带状疱疹临床疗效观察"", 《地方病通报》 * |
秦秀丽等: ""自拟瓜蒌解毒汤配合青黛雄黄散外敷治疗带状疱疹60例临床观察"", 《河北中医药学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535311A (zh) * | 2016-01-13 | 2016-05-04 | 刘志杰 | 一种治疗神经痛的中药 |
CN110179853A (zh) * | 2019-07-04 | 2019-08-30 | 鲁维德 | 一种治疗带状疱疹的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104288597B (zh) | 2017-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101934025B (zh) | 一种用于清热解毒的中药 | |
KR20240102982A (ko) | 두드러기, 습진, 알레르기/변태반응체질 치료를 위한 중약제제 | |
CN103211933B (zh) | 一种治疗骨质增生的中药 | |
CN102846803A (zh) | 一种治疗脚气的外用药物 | |
CN103479929A (zh) | 一种治疗瘙痒的中药组合物 | |
CN101342355B (zh) | 一种用于治疗痛经的复方吴茱萸混合药剂 | |
CN111840383A (zh) | 一种治疗风湿性关节炎的靶向喷灸组合物及其制备、使用方法 | |
CN103385941B (zh) | 中草药止痛药灸 | |
CN109091658A (zh) | 一种治疗寒湿痹阻型痛症的中药组合物、膏方及其制备方法 | |
CN102512559B (zh) | 一种治疗肩周炎的中药组合物 | |
CN102302733B (zh) | 治疗卵巢囊肿的内服中药组合物 | |
CN102626508A (zh) | 一种治疗肝癌的中药组合物 | |
CN102614424A (zh) | 一种用于治疗水肿的中药 | |
CN104288597B (zh) | 一种治疗带状疱疹的中药组合物 | |
CN103007063B (zh) | 一种治疗面瘫的药物组合物及其制备方法 | |
CN102580142B (zh) | 一种用于骨科手术术后愈合的中药敷药及制备方法 | |
CN101890117B (zh) | 治疗痤疮的中药组合物 | |
CN108771729A (zh) | 一种通痹中药熏洗剂及其制备方法 | |
CN103768368B (zh) | 一种治疗急性附睾炎的中药组合物 | |
CN103585596B (zh) | 一种用于治偏头痛的中药组合物 | |
CN103495103B (zh) | 消食健脾的药物 | |
CN103505702B (zh) | 一种治疗肝胃不和证型胁痛病的中药 | |
CN102861292B (zh) | 一种治疗食管癌的药物及其制备方法 | |
CN102205067B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN105641128A (zh) | 一种治疗带状疱疹的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170825 Termination date: 20180919 |